Harvard 3rd Annual Update in Neuro-Oncology 2023

Harvard 3rd Annual Update in Neuro-Oncology 2023

Include: 39 videos + 32 pdfs, size: 12.05 GB

Target Audience: neurologists, oncologists, neurosurgeons, radiation oncologists, pathologists

 Information:

Neuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, radiation and surgical management of pediatric and adult patients with primary and metastatic tumors of the central nervous system (CNS) and peripheral nervous system (PNS). In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification. This three-day course, Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors and neurological complications of cancer.

Our target audience will be the providers involved in the care of adult and pediatric neuro-oncology patients (oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists and neuropathologists). The course will also be of high relevance to nurse practitioners, physician assistants, psychologists, pharmacists and nurses.

Who Should Attend

• Specialty Physicians
• Nurses, Pharmacists
• Physician Assistants
• Psychologists

Learning Objectives

Upon completion of this activity, participants will be able to:

• Identify the role of biomarkers in the diagnosis of pediatric and adult CNS and PNS tumors.
• Identify standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
• Recognize and address neurological complications associated with new cancer therapies.
• Identify and manage long-term complications of CNS and PNS tumors and their treatment.

🧠 The Harvard 3rd Annual Update in Neuro-Oncology 2023 is best for neurologists, oncologists, neurosurgeons, radiation oncologists, pathologists, and other healthcare professionals involved in the care of patients with central and peripheral nervous system tumors. It’s ideal for:

👩‍⚕️ Who Should Attend

• Clinicians treating primary and metastatic brain and spine tumors
• Specialists managing neurological complications of cancer
• Researchers and educators seeking updates on molecular neuropathology and neuroradiology

📅 Dates: July 26–28, 2023

 Topics: